Prudential Financial’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18K Buy
15,930
+4,045
+34% +$4.57K ﹤0.01% 2408
2025
Q1
$17.4K Buy
+11,885
New +$17.4K ﹤0.01% 2260
2024
Q4
Sell
-214,495
Closed -$601K 2289
2024
Q3
$601K Sell
214,495
-17,401
-8% -$48.7K ﹤0.01% 2136
2024
Q2
$540K Buy
231,896
+33,484
+17% +$78K ﹤0.01% 2152
2024
Q1
$887K Sell
198,412
-180,428
-48% -$807K ﹤0.01% 1907
2023
Q4
$1.22M Buy
+378,840
New +$1.22M ﹤0.01% 1721
2023
Q3
Sell
-33,890
Closed -$168K 2595
2023
Q2
$168K Sell
33,890
-54,541
-62% -$271K ﹤0.01% 2450
2023
Q1
$437K Buy
+88,431
New +$437K ﹤0.01% 2133
2021
Q1
Sell
-102,036
Closed -$2.58M 2489
2020
Q4
$2.58M Sell
102,036
-162,346
-61% -$4.1M ﹤0.01% 1305
2020
Q3
$9.97M Buy
264,382
+248,237
+1,538% +$9.36M 0.02% 655
2020
Q2
$692K Buy
+16,145
New +$692K ﹤0.01% 1801